Almost four and a half years ago, then minister for health Dr James Reilly ordered the Health Service Executive not to destroy more than one million blood samples taken from newborn children in the Republic between 1984 and 2002.
The heel-prick tests, known as Guthrie tests, are carried out on all babies to screen for genetic conditions.
The decision to destroy the cards with the blood samples on them came after it emerged that those taken before July 1st, 2011, were being retained without consent, and therefore in breach of national and EU data protection law.
The Royal College of Physicians at the time said there was an explosion of molecular genetics every day that was being added to and that the museum piece cards could prove to be even more valuable in the future.
The Irish Heart Foundation, which had campaigned to save the cards, said some 1,400 families that had lost a member through sudden adult death syndrome would, as a result, be able to get a genetic diagnosis to see if they were at risk.
The debate over those cards and the legality of retaining them still rumbles on, as do ethical questions about the privacy of highly sensitive medical data obtained for one purpose and whether it should ever be used for another without the consent of the original subject, in the absence of a legal exemption.
Meanwhile, medical and scientific researchers are closely watching the new EU General Data Protection Regulation (GDPR) and what it might mean for them and their work after it takes effect next May.
While the regulation allows certain exemptions for processing special cateogories of data, including genetic and biometric data, the Irish legislation hasnt been written yet and researchers are waiting to see what it will mean for their work.
In some cases, they are worried about what the new law will mean for historic datasets and longitudinal studies and whether they will have to delete them on the grounds that they will not have the appropriate standards of explicit consent post May 2018 to retain them.
Even in just a few years, the medical, legal, ethical and social dilemmas involved in processing health data, including biological samples obtained from patients or research study volunteers have become vastly more complex.
The ethical issues that arise around areas such as stem cell research, embryo research and reproductive cloning, genome sequencing, gene editing and population-scale biobanks are huge.
Opportunities for uncovering the causes of disease, for resolving fertility issues, for fixing genetic conditions, for treating cancers, are within the grasp of scientists and researchers, but there is still no international consensus on many issues.
Concerns are evolving too in light of new models for funding research, such as venture capital-backed projects where highly sensitive data used for research, and effectively a permanent record, may ultimately end up being used by or sold for profit to companies or other third parties anywhere in the world.
Researchers are still uncertain what exactly the GDPR will mean for them in terms of the exemptions from data protection legislation that will apply to so-called special categories of data including genetic and biometric health data used for research.
At a recent event in Dublin, the Irish Platform for Patients Organisations, Science and Industry (IPPOSI) explored the concerns about data protection, consent and the forthcoming regulation.
IPPOSI chief executive Dr Derick Mitchell told the event: Patients are aware that the altruistic benefit of being involved in research far outweighs the risks, but they do expect that they will be consulted on the use of their data.
He said empowerment of the data owner was fundamental to the forthcoming changes in the law, and the event explored a model of so-called dynamic consent to allow people consent to have their data used for research, possibly allowing broad consent at the outset and opt-outs at a later stage where they did not agree to new uses. The legal jury is still out on whether such a model is even possible.
Dr Mitchell said a national response was required to GDPR and not just for health research.
He hoped that guidance on the question of consent for processing of personal data expected later in the year from the independent body representing all of the EUs national data protection authorities would be a step forward.
But I think the real crux is the code of conduct and each institution in effect will have to develop their own code of conduct as to how they approach data protection from the beginning of projects rather than having it as a kind of tick-box exercise at the end of a project, he said.
Dr Mitchell said the explicit consent referred to in the EU regulation, for example, had very real consequences for the continuation of large-scale population biobanks, for example.
There was also an ethical argument going on as to whether a persons consent could be said to be informed if they ultimately did not know what the research project might ultimately examine.
Prof Jane Grimson, a member of the e-health Ireland committee and a former director of Health Information in the Health Information and Quality Authority, said the potential of health data and research had to be balanced with a patients right to privacy.
Ownership of patient records was critical, she said.
I think the way we are moving now is much more towards electronic health records that will be owned and controlled by the individual. Its their information and they should be in control of who has a right to see information and the information (that is used in research).
Ethics research committees were critical and needed to operate to a very high standard to ensure the trust of people, she added.
Its an absolute minefield but I really think that ethics committees are critical.
Prof Orla Sheils, director of the Trinity Translational Medicine Institute and director of medical ethics at the School of Medicine, TCD, said she believed GDPR would have immediate consequences for data already being processed by researchers. It was a very grey area.
The difficulty with that is that if data has been collected over a long period of time that a person may not want to be reminded of the time that they were ill. Thats the balance you are trying to find there. So the way to get around that is to try to give people enough options up front to decide yes, I want to gift my sample and provided the research thats going to be done is ethical and has been approved, thats okay by me.
Prof Sheils, who sits on the St Jamess and Tallaght hospital research ethics committee, said all research involving humans had to be approved by such a committee.
Its never an ethical issue if the answer is easy, she said.
Like everything else in life, its about finding that happy balance that people are comfortable with, she said.
There is never really a right answer when there is an ethical dilemma. What I always say to students is that you are hoping for the least bad option.
Cathal Ryan of the office of the Data Protection Commissioner told the IPPOSI event the new EU regulation would bring harmonisation, transparency and accountability to a very dense and complex area. The regulation was very pragmatic and the code of conduct within it would act as a form of self-regulation, with the additional oversight of an independent monitoring body. But he said adequate transparency on data protection in the sector had been lacking.
If there is an erosion of trust, if the health sector doesnt treat an individuals data in the right way, there will be problems.
Read more here:
Should your medical data be off the record? - The Irish Times - Irish Times
- The Science Of Health: Are Spinal Cord Injuries Irreversible? Know Science Advances That Can Cure Them In The Future - ABP Live - October 16th, 2023
- Biden Weaponized Health Care on Abortion, Transgender, COVID-19 - Daily Signal - April 23rd, 2023
- Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval? - Marketscreener.com - November 17th, 2022
- BIOADAPTIVES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com - November 17th, 2022
- With fewer inmates (and officers), Michigan closes another prison - Bridge Michigan - September 12th, 2022
- Testol 140 Review, Real Testol-140 Reviews Before and After Results - Dailyuw - September 12th, 2022
- Can California deliver on its zero-emission car goal? - Los Angeles Times - September 12th, 2022
- Researchers revive abandoned technique in effort to make artificial human eggs in a test tube - STAT - August 3rd, 2022
- 'Incredibly prejudicial': Why Sacramento courts have caged cells, and why that'll change - Walla Walla Union-Bulletin - August 3rd, 2022
- Ethical Issues in Stem Cell Research - PubMed Central (PMC) - December 22nd, 2021
- Dream Body Clinic Stem Cell Therapy Stem Cells HGH - December 22nd, 2021
- Stem cells | healthdirect - December 22nd, 2021
- Human Embryonic Stem Cells | The Embryo Project Encyclopedia - December 22nd, 2021
- Stem cells, through a religious lens Harvard Gazette - December 22nd, 2021
- Scientists identify 2nd HIV patient whose body rid itself of virus - National Herald - November 21st, 2021
- Need to streamline research on CRISPR gene-editing technology: Experts - Business Standard - November 21st, 2021
- Atrial Fibrillation Market Growth Driven by Technological Advancements in AFib Systems and Solutions and Rapidly Increasing Geriatric Population -... - November 21st, 2021
- Could Regenerative Biology Work in Humans? - Harvard Magazine - July 21st, 2021
- Alberta and NWT Bishops OK vaccination for COVID Grandin Media - Grandin Media - December 3rd, 2020
- The way prisoners flag guard abuse, inadequate health care and unsanitary conditions Is broken - injusticewatch.org - December 3rd, 2020
- From Roaches To Medical Emergencies, Illinois Inmates Say Theres Nobody That We Can Really Go To For Help - WBEZ - December 3rd, 2020
- Alexion Receives Marketing Authorization from European Commission for New Formulation of ULTOMIRIS (ravulizumab) with Significantly Reduced Infusion... - November 20th, 2020
- California's Stem Cell Agency Will Get A Funding Boost From Prop 14. Here's A Look At Its History. - Capital Public Radio News - November 19th, 2020
- Stem Cell Banking Market is Projected to Reach $6,956 million by 2023 | Leading key players are Cord Blood Registry, ViaCord, Cryo-Cell, China Cord... - November 19th, 2020
- Locked up during the Waupun COVID surge - Wisconsin Examiner - November 19th, 2020
- Panelists debate the implications and ethics of stem cell research - Johns Hopkins News-Letter - November 2nd, 2020
- Rapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's US Manufacturing Facility... - November 2nd, 2020
- Is the Pro-Life Movement on a Collision Course with the Coronavirus? - The Dispatch - November 2nd, 2020
- Will Trevor Lawrence stay at Clemson to avoid the Jets? - Yahoo! Voices - November 2nd, 2020
- Spurs' Becky Hammon honored with impressive San Antonio mural - Yahoo! Voices - November 2nd, 2020
- Total Student Enrollment of China New Higher Education Group Achieves Strong Organic Growth to a New Record High -- Total Number of Enrolled Students... - November 2nd, 2020
- Elis announces the acquisition of 3 laundries in Brazil - Yahoo Finance UK - November 2nd, 2020
- Stem Cell Banking Market is forecast to reach $6,956 million by 2023 | ViaCord,Cryo-Cell, China Cord Blood Corporation, Cryo-Save - The Daily... - October 2nd, 2020
- Those linked to stem cell board received more than $2.1 billion - Capitol Weekly - September 16th, 2020
- Patenting Stem Cell Inventions in India- What to Expect? - Lexology - September 13th, 2020
- Global Stem Cell Banking Market Is Projected To Witness Vigorous Expansion By 2026 - Kewaskum Statesman News Journal - September 13th, 2020
- How Close Are We To Making Babies from Bone Marrow? - Discover Magazine - August 12th, 2020
- India could bleed itself dry amidst covid-19 crisis owing to blood shortage - ETHealthworld.com - July 12th, 2020
- Court rules controversial stem cell research is legal - July 10th, 2020
- Legal Issues in Stem Cell Therapy in the U.S. - Inventus Law - June 19th, 2020
- Restoring vision to the blind - Science Magazine - May 22nd, 2020
- Death of a Survivor - The New Republic - May 4th, 2020
- Could Cannabis Be an Effective Treatment for COVID-19? - Lab Manager Magazine - April 29th, 2020
- The Republicans who were once so pro-life they fought over one woman on life support now want to sacrifice grandma for the economy - The Independent - April 29th, 2020
- Russia's Humanitarian Law Obligations to Civilians in Occupied Ukrainian Territories in the Time of COVID-19 - Just Security - April 29th, 2020
- Merck Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity - PR Newswire UK - April 22nd, 2020
- Insights Into the $8.8 Billion Cell Therapy Industry, 2020-2027 - Rising Adoption of Regenerative Medicine, Introduction of Novel Platforms &... - March 17th, 2020
- The tragic life of Meredith Vieira - Nicki Swift - March 17th, 2020
- The 411 on Stem Cells: What They Are and Why It's Important to Be Educated - Legal Examiner - February 20th, 2020
- The Challenge of Bioethics to Decision-Making in the UK - Westminster Abbey - February 20th, 2020
- Penn announces seven 2020 Thouron Award winners - Penn: Office of University Communications - February 20th, 2020
- BrainStorm Cell Therapeutics to Present at the 2020 Biotech Showcase and 3rd Annual Neuroscience Innovation Forum at JPM Week - GlobeNewswire - January 7th, 2020
- Drugs, Biologics, and Regenerative Medicine in 2019: A Successful Year Ends with Promise of a More Challenging 2020 - JD Supra - December 21st, 2019
- Edited Transcript of MRKR.OQ earnings conference call or presentation 12-Nov-19 10:00pm GMT - Yahoo Finance - November 29th, 2019
- BrainStorm Announces Financial Results for the Third Quarter of 2019 and Provides a Corporate Update - GlobeNewswire - November 19th, 2019
- What to Know in Washington: Trump Ally in Impeachment Spotlight - Bloomberg Government - November 19th, 2019
- Do transhumanists need their own bill of rights? - Quartz - October 27th, 2019
- Does Stem Cell Therapy Work For Back Pain? - Regenexx - October 8th, 2019
- The Ethical, Social & Legal Issues of Cloning Animals ... - October 8th, 2019
- An Overview of Stem Cell Research | The Center for ... - October 5th, 2019
- Ethical Issues in Stem Cell Research | Endocrine Reviews ... - October 2nd, 2019
- Embryo - Wikipedia - October 2nd, 2019
- Legal Issues in Stem Cell Therapy in the U.S. - Royse Law Firm - September 14th, 2019
- Research With Stem Cells | American Medical Association - May 23rd, 2019
- Practical Problems with Embryonic Stem Cells - usccb.org - March 17th, 2019
- Stem Cells For Dummies: The Controvery, Pros and Cons ... - March 6th, 2019
- Human cloning - Wikipedia - February 18th, 2019
- stem cell | Definition, Types, Uses, Research, & Facts ... - December 12th, 2018
- Timeline of major events in stem cell research policy ... - August 25th, 2018
- stem-cells | ETHICAL, LEGAL, AND SOCIAL ISSUES - July 29th, 2018
- The Legal and Ethical Issues of Cloning That Make it ... - October 11th, 2017
- 5 Ethical and Legal Issues | Cord Blood: Establishing a ... - September 21st, 2017
- FDA Grants Orphan Drug Status to Cellect's ApoGraft for Acute GvHD and Chronic GvHD - PR Newswire (press release) - September 5th, 2017
- Of cell phones and swords things Amarilloans should know about new state laws - Amarillo.com - September 1st, 2017
- Cellect Shares Will Be Traded From Next Week Exclusively on NASDAQ - PR Newswire (press release) - September 1st, 2017
- ICMR to release stem cell research guidelines soon - BSI bureau (press release) - September 1st, 2017
- ICMR's stem cell research guidelines soon to be released - ETHealthworld.com - August 31st, 2017
- Combatting the spread of anti-vaccination sentiment - OUPblog (blog) - August 25th, 2017
- Embryonic stem cell - Wikipedia - August 24th, 2017
- How processing health data has become increasingly problematic - Irish Times - August 24th, 2017